This document discusses gastrointestinal manifestations and liver injury associated with COVID-19. It finds that SARS-CoV-2 RNA has been detected in anal/rectal swabs in 54% of cases. Common GI symptoms in patients with COVID-19 include diarrhea, vomiting, and abdominal pain. Between 14.8-53.1% of COVID-19 patients show abnormal liver enzymes. The document also discusses GI complications seen in critically ill COVID-19 patients such as bowel ischemia, bleeding, and pancreatitis. Local surgical data found colon perforation and mesenteric ischemia to be common GI indications for surgery post-COVID-19 with a 40% mortality rate for those requiring abdominal surgery.